aaronmd.com
Encouraging News For Treatment Of HER2-positive Early Breast Cancer - Breast Cancer Treatment Surgeon Knoxville, TN - Dr. Aaron Margulies FACS
I’m excited to share news about a significant advancement in treatment for patients with HER2-positive early breast cancer. A phase III trial shows that a treatment called Kadcyla® (TDM-1) lowered the risk of recurrence of invasive breast cancer or death by 50% compared to Herceptin® in patients with HER2-positive early breast cancer with residual disease …